4//SEC Filing
Klausner Mark R. 4
Accession 0001437749-18-003793
CIK 0001586049other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:31 PM ET
Size
7.3 KB
Accession
0001437749-18-003793
Insider Transaction Report
Form 4
Klausner Mark R.
Director
Transactions
- Award
SHARE OPTION (RIGHT TO BUY)
2018-03-01+3,728→ 3,728 totalExercise: $10.93Exp: 2028-03-01→ ORDINARY SHARES (3,728 underlying) - Award
SHARE OPTION (RIGHT TO BUY)
2018-03-01+14,914→ 14,914 totalExercise: $10.93Exp: 2028-03-01→ ORDINARY SHARES (14,914 underlying)
Footnotes (2)
- [F1]This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant.
- [F2]This option will vest and become exercisable as to one-third of the shares on each date on which the first three annual meetings of the issuer's shareholders are held after the date of grant.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001732629
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:31 PM ET
- Size
- 7.3 KB